Skip to main content
Clinical Trials/CTRI/2023/08/056593
CTRI/2023/08/056593
Not yet recruiting
Phase 1

Effect of Retro walking as an Adjunct to conventional treatment on Pain, Balance, Gait, Muscle strength, Flexibility, Functional disability and Mobility in patients with knee Osteoarthritis - not applicable

Jamia Millia Islamia0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: M171- Unilateral primary osteoarthritisof knee
Sponsor
Jamia Millia Islamia
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • a) Individuals fulfilling, clinical criteria listed by the American College of Rheumatology: knee pain and any three out of the following six criteria (age \>50 years; morning stiffness lasting \<30 min; crepitus on active motion; bony tenderness; bony enlargement; and no warmth on touch (Wu CW, et al. 2005\).
  • b)Individuals on Grade 2 and 3 or mild to moderate as per Kellgren and Lawrence scale.
  • c)Individuals with knee pain for more than 6 weeks.
  • d)Age: above 40 (male and female).
  • e)Patient with body mass index less than 25 kg/m2
  • f)In case of bilateral involvement more severely involve knee will be considered.
  • g)Patients with pain less than 7 or equal to 3 or more on the Numerical Pain Rating Scale

Exclusion Criteria

  • Individuals will be excluded from the study if they will have.
  • a)Any underlying pathology, History of ankle disease, Congenital deformities, other systemic arthritis, recent surgeries, trauma, or fractures of the lower limb
  • b)Known cases of severe osteoporosis.
  • c)With any neurological disorder including balance issues and motor and sensory loss.
  • d)Taking intraarticular injection for knee pain for the last 6 months
  • e)Presence of acute joint effusion
  • f)Individuals having visual dysfunction or refractory errors are not corrected with glasses or contact lenses.
  • g)Individuals having baseline history of established coronary artery disease (CAD), typical angina or heart failure.
  • h)Patient with metal implant or cardiac pacemaker.
  • i)Patients with uncontrolled arterial hypertension, atrial fibrillation or flutter, hypertrophic and dilated cardiomyopathy, valvular heart disease, cerebrovascular disease (history of stroke, transient ischemic attacks, or carotid artery surgery), are contraindicated to the exercise test were not included in the study. (American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription (8th edition).

Outcomes

Primary Outcomes

Not specified

Similar Trials